Weight gain in your 30s can feel like an unwelcome surprise. Jeans that once fit snugly now gather dust, replaced by looser clothes as hormones, stress, post-pregnancy changes, and a slowing metabolism take their toll. For many women, this creeping weight gain becomes a persistent challenge.
Enter Mounjaro, the latest injectable medication gaining popularity as a weight loss aid. Originally developed to manage type 2 diabetes, this weekly shot—known scientifically as tirzepatide—mimics gut hormones that control appetite and insulin.
It helps users feel full sooner, reduces cravings, and improves blood sugar regulation. Though approved for diabetes, it’s increasingly prescribed off-label for weight loss, especially among people struggling with obesity.
Dr. Sukrit Singh Sethi, Director and Senior Consultant at Narayana Hospital, explains: “Mounjaro is designed for type 2 diabetes, but women over 30 are now using it, either off-label or through approved alternatives, to lose weight.”
Clinical trials have shown remarkable results, with women losing up to 24.6% of their body weight—a substantial and sustainable reduction. Men in the same studies lost around 18.1%. This has sparked hope for women who’ve battled stubborn weight for years.
Why do women in their 30s show particular interest? At this age, hormonal shifts, declining muscle mass, and conditions like PCOS or insulin resistance can make weight loss difficult. Sedentary lifestyles and post-pregnancy changes compound the problem.
Dr. Rajiv Kovil, Head of Diabetology at Zandra Healthcare, notes, “Women over 30 are especially prone to chronic weight gain. Mounjaro offers a chance to reset metabolic health.”
Notably, the SURMOUNT clinical trials included a large number of female participants, providing valuable insights into how the drug functions in women.
However, Mounjaro is not without risks. Gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation are common, especially during the initial weeks of treatment. These symptoms usually improve as the body adapts or the dosage is adjusted, but can still be unpleasant.
More serious, though rare, risks include pancreatitis, gallbladder issues, and potential kidney problems—particularly if hydration is inadequate.
The FDA has issued a black box warning about a possible link to thyroid cancer based on animal studies. Women with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome should avoid Mounjaro entirely.
Additional concerns include temporary hair loss, hormonal imbalances, mood changes, and potential impacts on bone health caused by rapid weight loss. Experts advise combining the drug with strength training and proper nutrition to mitigate these risks.
For women worried about fertility, current clinical data does not show any negative effects on menstrual cycles or reproductive hormones. Still, pregnancy should be avoided during and shortly after treatment due to limited safety data.
Is Mounjaro right for you? Experts emphasize that it is not a quick fix or a casual wellness trend. “Proper medical screening, a comprehensive nutrition plan, lifestyle adjustments, and ongoing monitoring are essential,” says Dr. Satish Chander Wasoori, Senior Consultant-Endocrinology at Paras Health.
Used responsibly, Mounjaro can provide a valuable boost when natural metabolism slows. But it should complement—not replace—healthy habits and self-care.
Women in their 30s and beyond considering Mounjaro should consult their healthcare providers, weigh the benefits against the risks, and remember that overall health—mental and physical—remains the ultimate priority.
Related topics:
